ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.760
+0.030 (1.73%)
Nov 21, 2024, 4:00 PM EST - Market closed

ESSA Pharma Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2014
Net Income
-27.67-26.58-35.1-36.81-23.45-12.76
Upgrade
Depreciation & Amortization
0.10.120.120.110.11-
Upgrade
Loss (Gain) From Sale of Investments
-0.85-0.670.07---
Upgrade
Stock-Based Compensation
5.385.017.899.487.521.15
Upgrade
Other Operating Activities
-0.310.01-0.2-0.140.070.62
Upgrade
Change in Accounts Receivable
-0.05-0.130.48-0.160.09-0.06
Upgrade
Change in Accounts Payable
0.171.24-1.632.67-0.05-1.01
Upgrade
Change in Income Taxes
-----0.02-0
Upgrade
Change in Other Net Operating Assets
-0.61.230.37-0.56-1.26-0.18
Upgrade
Operating Cash Flow
-23.84-19.78-28-25.42-16.98-12.25
Upgrade
Investment in Securities
70.5-3.53-53.05-35.03-22.01-
Upgrade
Other Investing Activities
---0.010.270.2
Upgrade
Investing Cash Flow
70.5-3.53-53.05-35.01-21.740.2
Upgrade
Long-Term Debt Repaid
--0.14-0.13-0.1-4.01-2.81
Upgrade
Net Debt Issued (Repaid)
-0.03-0.14-0.13-0.1-4.01-2.81
Upgrade
Issuance of Common Stock
0.880.070.39151.3249.3336
Upgrade
Other Financing Activities
----9.23-3.5417.37
Upgrade
Financing Cash Flow
0.85-0.070.25141.9941.7850.56
Upgrade
Foreign Exchange Rate Adjustments
000.05-0.06-0.06-0.02
Upgrade
Net Cash Flow
47.52-23.37-80.7581.5338.49
Upgrade
Free Cash Flow
-23.84-19.78-28-25.42-16.98-12.25
Upgrade
Free Cash Flow Per Share
-0.54-0.45-0.64-0.66-0.76-1.45
Upgrade
Cash Interest Paid
----0.030.4
Upgrade
Levered Free Cash Flow
-16.1-12.62-15.88-11.68-8.92-5.7
Upgrade
Unlevered Free Cash Flow
-16.1-12.62-15.87-11.67-8.78-5.32
Upgrade
Change in Net Working Capital
0.41-2.340.78-1.961.71-1.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.